Conversion of major ginsenoside Rb1 to 20(S)-ginsenoside Rg3 by Microbacterium sp GS514

被引:147
作者
Cheng, Le-Qin [1 ,2 ]
Na, Ju Ryun [1 ]
Bang, Myun Ho [1 ]
Kim, Myung Kyum [1 ]
Yang, Deok-Chun [1 ]
机构
[1] Kyung Hee Univ, Coll Life Sci, Dept Oriental Med Mat & Proc, Kyunggido 449701, South Korea
[2] Jilin Inst Chem Technol, Dept Pharm & Appl Chem, Jilin, Peoples R China
关键词
conversion; 20(S)-ginsenoside Rg3; ginsenoside Rb1; Microbacterium sp GS514;
D O I
10.1016/j.phytochem.2007.06.035
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ginseng saponin, the most important secondary metabolite in ginseng, has various pharmacological activities. Many studies have been directed towards converting major ginsenosides to the more active minor ginsenoside, Rg3. Due to the difficulty in preparing ginsenoside Rg3 enzymatically, the compound has been mainly produced by either acid treatment or heating. A microbial strain GS514 was isolated from soil around ginseng roots in a field and used for enzymatic preparation of the ginsenoside Rg3. Blast results of the 16S rRNA gene sequence of the strain GS514 established that the strain GS514 belonged to the genus Microbacterium. Its 16S rRNA gene sequence showed 98.7%, 98.4% and 96.1% identity with those of M. esteraromaticum, M. arabinogalactanolyticum and M. lacticum. Strain GS514 showed a strong ability to convert ginsenoside Rb1 or Rd into Rg3. Enzymatic production of Rg3 occurred by consecutive hydrolyses of the terminal and inner glucopyranosyl moieties at the C-20 carbon of ginsenoside Rb1 showing the biotransformation pathway: Rb1 -> Rd -> Rg3. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:218 / 224
页数:7
相关论文
共 26 条
[1]   Synthesis of ginsenoside Rg3, a minor constituent of Ginseng Radix [J].
Anufriev, VP ;
Malinovskaya, GV ;
Denisenko, VA ;
Uvarova, NI ;
Elyakov, GB ;
Kim, SI ;
Baek, NI .
CARBOHYDRATE RESEARCH, 1997, 304 (02) :179-182
[2]   Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities [J].
Bae, EA ;
Han, MJ ;
Choo, MK ;
Park, SY ;
Kim, DH .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (01) :58-63
[3]   Conversion of major ginsenoside Rb1 to ginsenoside F2 by Caulobacter leidyia [J].
Cheng, Le-Qin ;
Kim, Myung Kyum ;
Lee, Jun-Won ;
Lee, Youn-Jin ;
Yang, Deok-Chun .
BIOTECHNOLOGY LETTERS, 2006, 28 (14) :1121-1127
[4]   Microbial transformation of ginsenoside Rb1 by Rhizopus stolonifer and Curvularia lunata [J].
Dong, AL ;
Ye, M ;
Guo, HZ ;
Zheng, JH ;
Guo, D .
BIOTECHNOLOGY LETTERS, 2003, 25 (04) :339-344
[5]   DEGRADATION OF GINSENG SAPONINS UNDER MILD ACIDIC CONDITIONS [J].
HAN, BH ;
PARK, MH ;
HAN, YN ;
WOO, LK ;
SANKAWA, U ;
YAHARA, S ;
TANAKA, O .
PLANTA MEDICA, 1982, 44 (03) :146-149
[6]  
Jeong SM, 2004, MOL CELLS, V18, P383
[7]   IMMUNOMODULATING ACTIVITY OF GINSENOSIDE RG1 FROM PANAX-GINSENG [J].
KENAROVA, B ;
NEYCHEV, H ;
HADJIIVANOVA, C ;
PETKOV, VD .
JAPANESE JOURNAL OF PHARMACOLOGY, 1990, 54 (04) :447-454
[8]  
Kim C, 1998, J GINSENG RES, V22, P205
[9]   Stereospecific effects of ginsenoside Rg3 epimers on swine coronary artery contractions [J].
Kim, JH ;
Lee, JH ;
Jeong, SM ;
Lee, BH ;
Yoon, IS ;
Lee, JH ;
Choi, SH ;
Kim, DH ;
Park, TK ;
Kim, BK ;
Nah, SY .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (02) :365-370
[10]  
Kim MK, 2005, J MICROBIOL, V43, P456